What is 'miSignal Scan'?

It is a test by Craif Inc. that uses AI to analyze microRNA in urine to assess the risk of 10 types of cancer, including pancreatic cancer, from stage 1. It is a non-invasive test.

Where can I get this test?

According to the official website, it is available through partner medical institutions, select drugstores, and municipal programs. Please check the official website for details.

AI News NQ Analysis

Craif's Urine Cancer Test 'miSignal Scan' Wins Communication Contribution Award at the 38th 'Hit Product & Topic Product Awards' Hosted by Drug Magazine

NQ Score 50/100

AI Summary (NQ-processed)

Bio-AI startup Craif Inc. announced that its urine cancer test 'miSignal Scan' has won the 'Topic Award: Communication Contribution Award' at the 38th 'Hit Product & Topic Product Awards'. This recognizes the product's market impact and innovative marketing, strengthening its presence in the self-care market.

AI analysis data is not yet available.

Frequently Asked Questions

Q: What is 'miSignal Scan'?: A: It is a test by Craif Inc. that uses AI to analyze microRNA in urine to assess the risk of 10 types of cancer, including pancreatic cancer, from stage 1. It is a non-invasive test.
Q: What award did it win this time?: A: It won the 'Topic Award: Communication Contribution Award' at the 38th 'Hit Product & Topic Product Awards' hosted by Drug Magazine, recognizing its market impact.
Q: Where can I get this test?: A: According to the official website, it is available through partner medical institutions, select drugstores, and municipal programs. Please check the official website for details.